Zdrowie i gospodarka · 14/09/2022

Annual Summary Reporting Requirements Under the Right to Try Act

The Food and Drug Administration (FDA) is issuing a final rule requiring sponsors and manufacturers of investigational drugs under the Right to Try Act to submit an annual summary of their use by a specified deadline. This rule implements a provision in the Act that mandates the submission of this information to FDA.